Phase I Study of CC-486 Alone and in Combination With Carboplatin or Nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-3716
Full Text
Open PDFAbstract
Available in full text
Date
May 15, 2018
Authors
Publisher
American Association for Cancer Research (AACR)